Temporary Modelling Scientist Opportunity at Novo Nordisk A/S

Do you want to conduct PK/PD and exposure-response analyses to support the development of new drugs at Novo Nordisk in a one year temporary position? About the department: The Quantitative Clinical Pharmacology department supports the entire Novo Nordisk development portfolio with model-based analyses from first in human studies to registration. You will be part of a diverse team of dedicated modelling and clinical pharmacology scientists in our R&D Global Development organisation. The Job: As Modelling Scientist you will have an important role in the development of new drugs at Novo Nordisk, taking part in designing, analysing, interpreting, communicating and reporting quantitative clinical pharmacology information (e.g. population PK/PD and exposure-response analyses) at all stages of clinical drug development. You will be part of multidisciplinary project teams where you will be responsible for developing modelling analysis plans for the project and follow them to completion. Qualifications: You hold a university degree in a relevant area (Statistics, Engineering, Pharmacy or other), preferably with a supplementary Ph.D. You are fluent in English both orally and written. You have a strong background in pharmacokinetics, statistics and/or quantitative clinical pharmacology analyses and have hands-on experience using S-PLUS/R and/or NONMEM. You are innovative with a high degree of independence, result and quality oriented, and thrive in a continuously changing environment with tight deadlines. You appreciate an informal atmosphere and act as a dedicated team player. As your colleagues will have different academic backgrounds, good presentation, communication and negotiation skills are essential. At Novo Nordisk, we strive for excellence. As a world leader in diabetes care and a major player in haemostasis management, growth hormone therapy and hormone replacement therapy, we offer our employees opportunities for continuous growth. Contact: For further information, please contact Christoffer Wenzel Tornøe at +45 3075 8193. Deadline: 17 March 2013 - Apply here: http://novonordisk.com/careers/job_section/current_jobs.asp?jobid=12436BR&lCountry= Best regards Christoffer _______________________________________________ Christoffer Wenzel Tornøe, Ph.D. Director, Quantitative Clinical Pharmacology Novo Nordisk A/S Vandtårnsvej 108-110 DK-2860 Søborg Denmark +45 4444 8888 (phone) +45 3075 8193 (mobile) [email protected] Changing diabetes by supporting a UN Resolution Did you know that Novo Nordisk is changing diabetes by supporting the implementation of a UN Resolution on diabetes? Find out how http://www.novonordisk.com/about_us/changing-diabetes/un-resolution.asp This e-mail (including any attachments) is intended for the addressee(s) stated above only and may contain confidential information protected by law. You are hereby notified that any unauthorized reading, disclosure, copying or distribution of this e-mail or use of information contained herein is strictly prohibited and may violate rights to proprietary information. If you are not an intended recipient, please return this e-mail to the sender and delete it immediately hereafter. Thank you.